An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies

Human Reproduction Update

Volumn 12, Issue 5, 2006, Pages 513-518

  Weisz, Boaz ^a,b   Rodeck, Charles H ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Down's syndrome; Integrated screening; Nuchal translucency; Screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; INHIBIN A;

BLOOD ANALYSIS; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; INFERTILITY THERAPY; MATERNAL AGE; MEDICAL TECHNOLOGY; MULTIPLE PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; URINALYSIS;

BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY, MULTIPLE; PRENATAL DIAGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 33747883920     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dml021     Document Type: Review

References (69)

1. ACOG Committee Opinion #296 (2004) First-trimester screening for fetal aneuploidy. Obstet Gynecol 104,215-217.
2. Avgidou K, Papageorghiou A, Bindra R, Spencer K and Nicolaides KH (2005) Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 192,1761-1767.
3. Barkai G, Goldman B, Ries L, Chaki R, Dor J and Cuckle H (1996) Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 16,1111-1114.
4. Bindra R, Heath V, Liao A, Spencer K and Nicolaides KH (2002) One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: A prospective study of 15 030 pregnancies. Ultrasound Obstet Gynecol 20,219-225.
5. Bishop AJ, Marteau TM, Armstrong D, Chitty LS, Longworth L, Buxton MH and Berlin C (2004) Women and health care professionals' preferences for Down's Syndrome screening tests: A conjoint analysis study. BJOG 111,775-779.
6. Borrell A, Gonce A, Martinez JM, Borobio V, Fortuny A, Coll O and Cuckle H (2005) First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn 25,901-905.
7. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS and Wald NJ (1988) Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol 95,330-333.
8. Canini S, Prefumo F, Famularo L, Venturini PL, Palazzeso V and De Biasio P (2002) Comparison of first trimester, second trimester and integrated Down's syndrome screening results in unaffected pregnancies. Clin Chem Lab Med 40,600-603.
9. Cicero S, Curcio P, Papageorghiou A, Sonek J and Nicolaides K (2001) Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: An observational study. Lancet 358,1665-1667.
10. Cicero S, Bindra R, Rembouskos G, Spencer K and Nicolaides KH (2003) Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 23,306-310.
11. Cuckle HS, Wald NJ and Lindenbaum RH (1984) Maternal serum alpha-fetoprotein measurement: A screening test for Down syndrome. Lancet 1,926-929.
12. Cuckle HS, Wald NJ and Thompson SG (1987) Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94,387-402.
13. D'Alton M and Cleary-Goldman J (2005) First and second trimester evaluation of risk for fetal aneuploidy: The secondary outcomes of the FASTER Trial. Semin Perinatol 29,240-246.
14. Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF and Benn PA (2002) Antenatal Down syndrome screening in the United States in 2001: A survey of maternal-fetal medicine specialists. Am J Obstet Gynecol 187,1230-1234.
15. Forest JC, Masse J and Moutquin JM (1997) Screening for Down syndrome during first trimester: A prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Clin Biochem 30,333-338.
16. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH and Saller DN Jr (1997) Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 90,98-101.
17. Geipel A, Berg C, Katalinic A, Ludwig M, Germer U, Diedrich K and Gembruch U (2004) Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod Biomed Online 8,119-124.
18. Gissler M, Klemetti R, Sevon T and Hemminki E (2004) Monitoring of IVF birth outcomes in Finland: A data quality study. BMC Med Inform Decis Mak 4,3.
19. Hui PW, Tang MH, Lam YH, Yeung WS, Ng EH and Ho PC (2005) Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 25,234-238.
20. Knight GJ, Palomaki GE, Neveux LM, Smith DF, Kloza EM, Pulkkinen AJ, Williams J and Haddow JE (2005) Integrated serum screening for Down syndrome in primary obstetric practice. Prenat Diagn 25,1162-1167.
21. Krantz DA, Hallahan TW, Orlandi F, Buchanan P, Larsen JW Jr and Macri JN (2000) First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol 96,207-213.
22. Liao AW, Heath V, Kametas N, Spencer K and Nicolaides KH (2001) First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 16,1501-1504.
23. van Lith JM, Pratt JJ, Beekhuis JR and Mantingh A (1992) Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 12,801-806.
24. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade G, Berkowitz RL, Dugoff L, Craigo SD, Carr SR, Wolfe HM et al. (2004) First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 104,1222-1228.
25. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD et al. (2005a) First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353,2001-2011.
26. Malone FD, Cuckle H, Ball RH, Nyberg DA, Comstock CH, Saade G, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD et al. (2005b) Contingent screening for Trisomy 21 - results from a general population screening trial. Am J Obstet Gynecol 193,S29.
27. Marteau TM, Kidd J, Michie S, Cook R, Johnston M and Shaw RW (1993) Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: A randomized controlled trial. J Psychosom Obstet Gynaecol 14,185-196.
28. Maymon R and Shulman A (2004) Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 24,125-129.
29. Maymon R, Jauniaux E, Holmes A, Wiener YM, Dreazen E and Herman A (2001) Nuchal translucency measurement and pregnancy outcome after assisted conception versus spontaneously conceived twins. Hum Reprod 16,1999-2004.
30. Maymon R, Neeman O, Shulman A, Rosen H and Herman A (2005) Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: Another double trouble. Prenat Diagn 25,746-750.
31. Merkatz IR, Nitowsky HM, Macri JN and Johnson WE (1984) An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 148,886-894.
32. Meyers C, Adam R, Dungan J and Prenger V (1997) Aneuploidy in twin gestations: When is maternal age advanced? Obstet Gynecol 89,248-251.
33. Muller F, Dreux S, Lemeur A, Sault C, Desgres J, Bernard MA, Giorgetti C, Lemay C, Mirallie S, Beauchet A et al. (2003) Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Prenat Diagn 23,1073-1076.
34. Nassar AH, Martin D, Gonzalez-Quintero VH, Gomez-Marin O, Salman F, Gutierrez A and O'Sullivan MJ (2004) Genetic amniocentesis complications: Is the incidence overrated? Gynecol Obstet Invest 58,100-104.
35. National Down's Syndrome Screening Programme for England (2004) Antenatal screening - working standards. NHS.
36. NICE (2005) National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Clinical Excellence (NICE). Antenatal care: Routine care for the healthy pregnant woman. RCOG Press, London.
37. Nicolaides KH (2004) Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 191,45-67.
38. Nicolaides KH, Azar G, Byrne D, Mansur C and Marks K (1992) Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304,867-869.
39. Nicolaides KH, Spencer K, Avgidou K, Faiola S and Falcon O (2005) Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: Results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25,221-226.
40. Niemimaa M, Heinonen S, Seppala M, Hippelainen M, Martikmainen H and Ryynanen M (2001) First-trimester screening for Down's syndrome in in vitro fertilization pregnancies. Fertil Steril 76,1282-1283.
41. Oddens BJ, den Tonkelaar I and Nieuwenhuyse H (1999) Psychosocial experiences in women facing fertility problems - a comparative survey. Hum Reprod 14,255-261.
42. Palomaki GE, Kloza EM, Haddow JE, Williams J and Knight GJ (2005) Patient and health professional acceptance of integrated serum screening for Down syndrome. Semin Perinatol 29,247-251.
43. Pandya PP, Goldberg H, Walton B, Riddle A, Shelley S, Snijders RJ and Nicolaides KH (1995) The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 5,20-25.
44. Raty R, Anttila L, Virtanen A, Koskinen P, Laitinen P, Morsky P, Tiitinen A, Martikainen H and Ekblad U (2003) Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis. Prenat Diagn 23,1045-1048.
45. Rice JD, McIntosh SF and Halstead AC (2005) Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Prenat Diagn 25,234-238.
46. Schuchter K, Hafner E, Stangl G, Metzenbauer M, Hofinger D and Philipp K (2002) The first trimester 'combined test' for the detection of Down syndrome pregnancies in 4939 unselected pregnancies. Prenat Diagn 22,211-215.
47. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W and Nicolaides KH (1996) Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 103,999-1003.
48. Seeds JW (2004) Diagnostic mid trimester amniocentesis: How safe? Am J Obstet Gynecol 191,607-615.
49. Senat MV, Bernard JP, Boulvain M and Ville Y (2003) Intra- and interoperator variability in fetal nasal bone assessment at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 22,138-141.
50. Simpson JL (2005) Choosing the best prenatal screening protocol. N Engl J Med 353,2068-2070.
51. Spencer K and Nicolaides KH (2003) Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years experience. BJOG 110,276-280.
52. Spencer K, Macri JN, Aitken DA and Connor JM (1992) Free beta-hCG as first-trimester marker for fetal trisomy. Lancet 339,1480.
53. Spencer K, Spencer CE, Power M, Moakes A and Nicolaides KH (2000) One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG 107,1271-1275.
54. Spencer K, Spencer CE, Power M, Dawson C and Nicolaides KH (2003) Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years prospective experience. BJOG 110,281-286.
55. Szabo J and Gellen J (1990) Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester. Lancet 336,1133.
56. Tabor A, Philip J, Madsen M, Bang J, Obel EB and Norgaard-Pedersen B (1986) Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1,1287-1293.
57. Wald NJ (1994) What are we screening for? J Med Screen 1,205.
58. Wald NJ and Hackshaw AK (1997) Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 17,821-829.
59. Wald NJ and Leck I (2000) Antenatal and Neonatal Screening. Oxford University Press, Oxford.
60. Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE and Woodford FP (1977) Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1,1323-1332.
61. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE and Canick JA (1989) Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297,883-887.
62. Wald N, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B, Teisner B and Fuhrmann W (1992) First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. BMJ 305,28.
63. Wald NJ, Watt HC and Hackshaw AK (1999a) Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 341,461-467.
64. Wald NJ, White N, Morris JK, Huttly WJ and Canick JE (1999b) Serum markers for Down's syndrome in women who have had in vitro fertilisation: Implications for antenatal screening. Br J Obstet Gynaecol 106,1304-1306.
65. Wald NJ, Rish S and Hackshaw AK (2003a) Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Prenat Diagn 23,588-592.
66. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L and Mackinson AM (2003b) First and second trimester antenatal screening for Down's syndrome: The results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10,56-104.
67. Wald NJ, Rodeck C, Hackshaw AK and Rudnicka A (2004) SURUSS in perspective. BJOG 111,521-531.
68. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA et al. (2003) First-trimester screening for trisomies 21 and 18. N Engl J Med 349,1405-1413.
69. Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiensen M and Tabor A (2001) First trimester screening for Down syndrome and assisted reproduction: No basis for concern. Prenat Diagn 21,563-565.